Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Summary of Reportable Segments (Detail)

v3.21.2
Segment Information - Summary of Reportable Segments (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Segment Reporting Information [Line Items]          
Revenues $ 54,228 $ 34,646 $ 106,033 $ 65,072  
Gross profit 31,311 18,890 61,032 34,342  
Depreciation and amortization 7,759 6,765 15,133 13,179  
Asset impairments and write-downs 1,624 8 1,882 200,051  
Net loss (15,256) (24,825) (34,708) (261,166)  
Purchase of property, plant and equipment 5,072 1,445 9,611 11,475  
Purchase of intangibles 31 86 31 378  
Assets 363,523   363,523   $ 353,133
Eastern Region          
Segment Reporting Information [Line Items]          
Revenues 34,724 19,589 67,780 37,638  
Gross profit 24,402 12,199 45,565 22,960  
Depreciation and amortization 6,687 5,797 12,865 11,317  
Asset impairments and write-downs   7 259 196,851  
Net loss 2,746 (4,082) 3,482 (208,917)  
Purchase of property, plant and equipment 4,992 1,237 9,523 10,858  
Purchase of intangibles 31 86 31 304  
Assets 228,596   228,596   227,237
Western Region          
Segment Reporting Information [Line Items]          
Revenues 19,103 14,004 37,406 25,729  
Gross profit 7,004 6,290 15,583 11,051  
Depreciation and amortization 698 647 1,536 1,237  
Asset impairments and write-downs   1   253  
Net loss 668 705 3,167 617  
Purchase of property, plant and equipment 64 80 68 468  
Purchase of intangibles       0  
Assets 108,893   108,893   109,039
Other          
Segment Reporting Information [Line Items]          
Revenues [1] 401 1,053 847 1,705  
Gross profit (95) 401 (116) 331  
Depreciation and amortization 374 321 732 625  
Asset impairments and write-downs 1,624   1,623 2,947  
Net loss (18,670) (21,448) (41,357) (52,866)  
Purchase of property, plant and equipment 16 $ 128 20 149  
Purchase of intangibles       $ 74  
Assets $ 26,034   $ 26,034   $ 16,857
[1] Revenues from segments below the quantitative thresholds are attributable to an operating segment of the Company that includes revenue from the sale of CBD products throughout the United States. This segment has never met any of the quantitative thresholds for determining reportable segments nor does it meet the qualitative criteria for aggregation with the Company’s reportable segments.